Steris (STE) EBIT Margin (2018 - 2026)
Steris (STE) posted EBIT Margin of 19.15% for Q2 2026, down 4.0% on a QoQ basis from 19.94% in Q1 2026, and up 146.0% year-over-year from 7.78% in Q2 2025.
Powered by 
Analysis
Steris (STE) EBIT Margin (2018 - 2026) Analysis & Trends
Steris has reported EBIT Margin for 9 years, with the latest figure at 19.15% in Q2 2026.
- On a quarterly basis, EBIT Margin rose 146.0% year-over-year to 19.15% in Q2 2026; TTM through Jun 2026 was 18.91%, a 227.0% increase from a year earlier, with the FY2026 full-year figure at 18.56%, up 269.0% from the prior year.
- EBIT Margin was 19.15% for Q2 2026 at Steris, down from 19.94% in the prior quarter.
- The five-year high for EBIT Margin was 58.41% in Q1 2023, with the low at 28.09% in Q3 2022.
- Average EBIT Margin over 5 years is 16.46%, with a median of 16.93% recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: EBIT Margin surged 4651 bps in 2023, then plunged 4288 bps in 2024.
- Over 5 years, EBIT Margin stood at 17.15% in 2022, then rose by 2 bps to 17.45% in 2023, then climbed by 3 bps to 17.9% in 2024, then increased by 2 bps to 18.26% in 2025, then increased by 5 bps to 19.15% in 2026.
- The last three EBIT Margin figures came in at 19.15% (Q2 2026), 19.94% (Q1 2026), and 18.26% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.43 Bn | 177.83 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 124.55 Bn | 119.33 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.91 Bn | 109.10 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 105.51 Bn | 102.03 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 66.23 Bn | 65.69 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.46 Bn | 45.21 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 33.87 Bn | 32.41 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.08 Bn | 30.13 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.05 Bn | 20.56 Bn | 684.20 Mn | 19.15% |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn | 14.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.15% |
| Mar 31, 2026 | 19.94% |
| Dec 31, 2025 | 18.26% |
| Sep 30, 2025 | 18.20% |
| Jun 30, 2025 | 17.68% |
| Mar 31, 2025 | 14.60% |
| Dec 31, 2024 | 17.90% |
| Sep 30, 2024 | 16.53% |
| Jun 30, 2024 | 14.50% |
| Mar 31, 2024 | 15.52% |
| Dec 31, 2023 | 17.45% |
| Sep 30, 2023 | 15.47% |
| Jun 30, 2023 | 16.71% |
| Mar 31, 2023 | 58.41% |
| Dec 31, 2022 | 17.15% |
| Sep 30, 2022 | -28.09% |
| Jun 30, 2022 | 15.06% |
| Mar 31, 2022 | 11.90% |
| Dec 31, 2021 | 16.79% |
| Sep 30, 2021 | 9.73% |